Literature DB >> 12706232

Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells.

U Ingrid Richardson1, Carol J Watkins, Celine Pierre, Ismael H Ulus, Richard J Wurtman.   

Abstract

Oral administration of CDP-choline to rats raises plasma and brain cytidine levels and increases brain levels of phosphatidylcholine (PC). In contrast, in humans oral CDP-choline increases plasma levels of uridine. To determine whether uridine can also enhance PC synthesis, we developed an assay for CDP-choline, an immediate and rate-limiting precursor in PC synthesis, and measured this intermediate in clonal PC12 rat pheochromocytoma cells incubated with various concentrations of uridine or cytidine. Addition of uridine (50-100 microM) to the incubation medium caused significant elevations in UTP, CT, USAP and CDP-choline levels in PC12 cells. Uridine had no effect on the synthesis of diacylglycerol (DAG) or the activity of the phosphotransferase which catalyzes the synthesis of PC from DAG and CDP-choline. Hence uridine treatment was unlikely to inhibit the conversion of endogenous CDP-choline to PC. These results suggest the possibility that uridine may also enhance PC synthesis in intact brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706232     DOI: 10.1016/s0006-8993(03)02333-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis or release.

Authors:  Ismail H Ulus; Carol J Watkins; Mehmet Cansev; Richard J Wurtman
Journal:  Cell Mol Neurobiol       Date:  2006-04-25       Impact factor: 5.046

2.  Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat.

Authors:  Lei Wang; Meredith A Albrecht; Richard J Wurtman
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

Review 3.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 4.  Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Authors:  R J Wurtman; M Cansev; I H Ulus
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

5.  A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity.

Authors:  Tarmo P Roosild; Samantha Castronovo; Adelbert Villoso; Amy Ziemba; Giuseppe Pizzorno
Journal:  J Struct Biol       Date:  2011-08-10       Impact factor: 2.867

6.  Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats.

Authors:  Lei Wang; Amy M Pooler; Meredith A Albrecht; Richard J Wurtman
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 7.  Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.

Authors:  Mehmet Cansev; Richard J Wurtman; Toshimasa Sakamoto; Ismail H Ulus
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

8.  Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils.

Authors:  M Cansev; R J Wurtman
Journal:  Neuroscience       Date:  2007-08-01       Impact factor: 3.590

9.  Synaptogenesis: Modulation by Availability of Membrane Phospholipid Precursors.

Authors:  Mehmet Cansev
Journal:  Neuromolecular Med       Date:  2016-06-01       Impact factor: 3.843

10.  Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition.

Authors:  Marwa A Aboukhatwa; Ashiwel S Undieh
Journal:  BMC Neurosci       Date:  2010-01-27       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.